The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
GSK agrees to buy RAPT Therapeutics for $2.2B, adding ozureprubart to its pipeline and strengthening its respiratory and ...
Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...
A vaccine created by University of Georgia researchers to battle multiple life-threatening fungal infections is also ...
Researchers at the University of Southampton engineered four-pronged antibodies that cluster the CD27 immune receptor, strongly activating cancer-killing T cells.
Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...
Michael Rahe, an assistant professor of immunology at the North Carolina State College of Veterinary Medicine, has been ...
GSK (GSK.L) signed a definitive agreement to purchase US-based clinical-stage biopharmaceutical company Rapt Therapeutics for ...
Researchers have harnessed AI to expedite the creation of lightbulb-like intrabody probes that can track activity in living ...
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology Proceeds advance multiple programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results